Clinical Trials · NCT03936933
Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Breast Cancer
- Phase
- Phase 3
- Recruitment status
- Terminated
- Sponsor
- Eurofarma Laboratorios S.A.
- Enrollment
- 6
- Start date
- Oct 2020
- Locations
- 1 site, India
- Primary endpoint
- To evaluate and compare the pharmacodynamics